Product Code: ETC098207 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
Chloramphenicol is a broad-spectrum antibiotic drug used in the treatment of bacterial infections. It is commonly used as a topical ointment for the treatment of eye infections and also as an oral suspension or tablet to treat systemic bacterial infections. The drug has been widely used in Indonesia since the 1950s, though its use was restricted following safety concerns by pharmaceutical regulators such as USFDA and European Medicines Agency (EMA).
The usage of chloramphenicol has seen an increase in recent years due to its efficacy against certain bacteria that are resistant to other antibiotics. This resurgence has been driven by factors such as increasing awareness among consumers about the prevalence of multidrug-resistant pathogens, rising incidences of infectious diseases across Indonesia, and higher demand from medical professionals coupled with improved availability and affordability of generic formulations. Moreover, there have been advances in understanding how chloramphenicol works on different types of bacteria which have further boosted its popularity amongst clinicians.
The main drivers for increased use of chloramphenicol are: growing demand from medical professionals; rising prevalence of multidrug-resistant pathogens; increasing incidence rates for various infectious diseases including typhoid fever; better availability & affordability due to increased production through generics manufacturing; advancements in understanding how chloramphenicol works on different types of bacteria; government initiatives promoting rationalised use & responsible prescribing habits amongst physicians/ healthcare staff etc.
The COVID-19 pandemic has had a significant impact on the Indonesia chloramphenicol market. The outbreak of the virus has caused disruptions in supply chains and reduced demand from consumers, resulting in a decrease in sales for producers. Additionally, restrictions imposed by governments to contain the spread of the virus have limited transportation and access to raw materials, further impacting production capabilities.
The main challenge facing the Indonesia chloramphenicol industry is meeting international standards regarding quality control while still maintaining competitive pricing. As Indonesia competes with other countries such as India for global market share, manufacturers must ensure that their products meet stringent requirements set forth by regulatory bodies such as US FDA and EU EMA. Another challenge is finding alternative sources of raw materials due to restricted access or unavailability due to disruption caused by COVID-19 pandemic. Additionally, environmental regulations are also becoming increasingly strict which can pose challenges for companies trying to manufacture quality drugs at economically viable costs.
Some key players operating within the Indonesia chloramphenicol market include PT Darya Varia Laboratoria (DVL), Tempo Scan Pacific Tbk (TSP) and Generic Drug Industries (GDI). These companies have established reputations for providing high quality drugs and medications at competitive prices while adhering to rigorous safety standards required by regulatory authorities like US FDA and EU EMA.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Chloramphenicol Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Chloramphenicol Market Revenues & Volume, 2021 & 2031F |
3.3 Indonesia Chloramphenicol Market - Industry Life Cycle |
3.4 Indonesia Chloramphenicol Market - Porter's Five Forces |
3.5 Indonesia Chloramphenicol Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Indonesia Chloramphenicol Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Indonesia Chloramphenicol Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Indonesia Chloramphenicol Market Trends |
6 Indonesia Chloramphenicol Market, By Types |
6.1 Indonesia Chloramphenicol Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Chloramphenicol Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 Indonesia Chloramphenicol Market Revenues & Volume, By Above98% Purity, 2021-2031F |
6.1.4 Indonesia Chloramphenicol Market Revenues & Volume, By Above99% Purity, 2021-2031F |
6.2 Indonesia Chloramphenicol Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Chloramphenicol Market Revenues & Volume, By Chloramphenicol Eye Drops, 2021-2031F |
6.2.3 Indonesia Chloramphenicol Market Revenues & Volume, By Chloramphenicol Ointment, 2021-2031F |
6.2.4 Indonesia Chloramphenicol Market Revenues & Volume, By Other, 2021-2031F |
7 Indonesia Chloramphenicol Market Import-Export Trade Statistics |
7.1 Indonesia Chloramphenicol Market Export to Major Countries |
7.2 Indonesia Chloramphenicol Market Imports from Major Countries |
8 Indonesia Chloramphenicol Market Key Performance Indicators |
9 Indonesia Chloramphenicol Market - Opportunity Assessment |
9.1 Indonesia Chloramphenicol Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Indonesia Chloramphenicol Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Indonesia Chloramphenicol Market - Competitive Landscape |
10.1 Indonesia Chloramphenicol Market Revenue Share, By Companies, 2024 |
10.2 Indonesia Chloramphenicol Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |